Methylphenidate Hydrochloride Capsule, Extended Release
FDA Label NDC 0115-1737

41 label sections · Submitted to the FDA by Amneal Pharmaceuticals Of New York Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Of New York Llc for the product Methylphenidate Hydrochloride (NDC 0115-1737). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: abuse, misuse, and addiction, 1 indications and usage, 2.1 pretreatment screening, 2.2 dosage recommendations, 2.3 administration instructions, 2.4 dosage reduction and discontinuation, 3 dosage forms and strengths, 4 contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.